The European Commission (EC) adopted a new One Health action plan against antimicrobial resistance (AMR) in June 2017. There are three key objectives to the plan:
1. Make the EU a best practice region through better evidence, coordination, and surveillance
2. Boost research, development and innovation in order to control the spread of AMR
3. Shape the global agenda on AMR and the related risks
The EC recognizes that diagnostics are crucial for differentiating between bacterial and viral infections and identifying AMR, so that the most appropriate treatment can be given in a timely manner. Thus, the EC has stated that they will:
The full report can be viewed here.
Reference: European Commission. A European One Health Action Plan against Antimicrobial Resistance (AMR). June 29, 2017.